The Chronic Lymphocytic Leukemia Channel is supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), Johnson & Johnson (Gold), BeOne Medicines (Silver) and Lilly (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
EHA 2017 | HARMONY and CLL: the future of research and databases
Paolo Ghia, MD, PhD, from the San Raffaele Scientific Institute, Milano, Italy gives us an overview of the large complex data project, HARMONY, and its work on chronic lymphocytic leukemia (CLL). He notes that there are studies exploring the prognostic value of biomarkers in CLL and current research is focused on exploring the association of novel gene mutations, discovered via next-generation sequencing, with CLL. This interview was filmed at the European Hematology Association (EHA) 2017 Annual Congress in Madrid, Spain.
